Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial

Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM

Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation

Sanaregen receives FDA clearance for retinal degeneration clinical trial

Esperion to acquire Corstasis, expanding cardiovascular portfolio

ReviR Therapeutics doses first participant in First-in-Human Phase 1 clinical trial of RTX-117

BD receives FDA clearance for Surgiphor 1000mL irrigation system

United Therapeutics' ralinepag reduces risk of clinical worsening in pivotal PAH study

FDA accepts rusfertide NDA and grants priority review for polycythemia vera

UAE approves PYRUKYND for treatment of thalassaemia

Eli Lilly's Olumiant (baricitinib) receives positive European regulatory opinion for approval to treat adolescents with severe alopecia areata

Innovent Biologics' Jaypirca approved in China for new indication

FDA accepts sNDA for MR-141 for the treatment of presbyopia

Lupin's Brivaracetam Oral Solution approved by US FDA

Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA